1. Home
  2. MTDR vs KRYS Comparison

MTDR vs KRYS Comparison

Compare MTDR & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MTDR

Matador Resources Company

HOLD

Current Price

$53.36

Market Cap

5.4B

Sector

Energy

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$264.74

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTDR
KRYS
Founded
2003
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
7.8B
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
MTDR
KRYS
Price
$53.36
$264.74
Analyst Decision
Buy
Strong Buy
Analyst Count
13
10
Target Price
$58.75
$297.60
AVG Volume (30 Days)
1.8M
265.0K
Earning Date
05-26-2026
01-01-0001
Dividend Yield
2.77%
N/A
EPS Growth
N/A
128.00
EPS
6.09
6.84
Revenue
$3,696,277,000.00
$389,130,000.00
Revenue This Year
$14.52
$44.50
Revenue Next Year
N/A
$34.79
P/E Ratio
$8.88
$38.34
Revenue Growth
5.46
33.94
52 Week Low
$35.19
$123.03
52 Week High
$54.25
$298.30

Technical Indicators

Market Signals
Indicator
MTDR
KRYS
Relative Strength Index (RSI) 66.55 46.66
Support Level $41.43 $255.65
Resistance Level N/A $293.60
Average True Range (ATR) 2.03 12.27
MACD 0.28 -1.72
Stochastic Oscillator 80.29 25.98

Price Performance

Historical Comparison
MTDR
KRYS

About MTDR Matador Resources Company

Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business. The Company has two reportable business segments: exploration and production and midstream.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: